MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on April 27, 2007; DOI: 10.1124/mol.107.034330


This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
mol.107.034330v1
72/2/359    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bukiya, A. N.
Right arrow Articles by Dopico, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bukiya, A. N.
Right arrow Articles by Dopico, A. M.


Received for publication January 22, 2007.
Revised March 23, 2007.
Accepted for publication April 27, 2007.

{beta}1 (KCNMB1)-subunits mediate lithocholate activation of BK channels and dilation in small, resistance arteries

Anna N. Bukiya 1, Jianxi Liu 1, Ligia Toro 2, Alex M. Dopico 1*

1 The University of Tennessee HSC, Department of Pharmacology 2 UCLA, Department of Anesthesiology

* Address correspondence to: E-mail: adopico{at}utmem.edu

Abstract

Among the nongenomic effects of steroids, control of vasomotion has received increasing attention. Lithocholate (LC) and other physiologically relevant cholane-derived steroids cause vasodilation, yet the molecular targets and mechanisms underlying this action remain largely unknown. We demonstrate that LC (45 µ M) reversibly increases the diameter of pressurized resistance cerebral arteries by ~10%, which would result in ~30% increase in cerebral blood flow. LC action is independent of endothelial integrity, prevented by 55 nM iberiotoxin, and unmodified by 0.8 mM 4-aminopyridine, indicating that LC causes vasodilation via myocyte BK channels. Indeed, LC activates BK channels in isolated myocytes through a destabilization of channel long-closed states without modifying unitary conductance. LC channel activation occurs within a wide voltage range and at Ca2+ concentrations reached in the myocyte whether at rest or during contraction. Channel accessory {beta}1- subunits, which are predominant in smooth muscle, are necessary for LC to modify channel activity. In contrast, {beta}4-subunits, which are predominant in neuronal tissues, fail to evoke LC sensitivity. LC activation of cbv1+{beta}1 and native BK channels display identical characteristics, including EC50 (46 µM) and Emax ({approx}300 µM), strongly suggesting that the cbv1+{beta}1 complex is necessary and sufficient to evoke LC action. Finally, intact arteries from {beta}1-subunit knockout mice fail to relax in response to LC, although they are able to respond to other vasoactive agents. This study pinpoints the BK {beta}1-subunit as the molecule that senses LC, which results in myocyte BK channel activation and, thus, endothelial-independent relaxation of small, resistance arteries.


Key words: Ion channel regulation, Calcium (Votage-Gated Channels), Potassium, Func. analysis receptor/ion channel mutants, Single channel kinetics, Structure/function/mechanism, Ischemia/Reperfusion


This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
N. J. Rusch
BK channels in cardiovascular disease: a complex story of channel dysregulation
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1580 - H1582.
[Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
M. Tong and R. K. Duncan
Tamoxifen inhibits BK channels in chick cochlea without alterations in voltage-dependent activation
Am J Physiol Cell Physiol, July 1, 2009; 297(1): C75 - C85.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
S. Hou, S. H. Heinemann, and T. Hoshi
Modulation of BKCa Channel Gating by Endogenous Signaling Molecules
Physiology, February 1, 2009; 24(1): 26 - 35.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
A. N. Bukiya, J. McMillan, A. L. Parrill, and A. M. Dopico
Structural determinants of monohydroxylated bile acids to activate {beta}1 subunit-containing BK channels
J. Lipid Res., November 1, 2008; 49(11): 2441 - 2451.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Liu, T. Vaithianathan, K. Manivannan, A. Parrill, and A. M. Dopico
Ethanol Modulates BKCa Channels by Acting as an Adjuvant of Calcium
Mol. Pharmacol., September 1, 2008; 74(3): 628 - 640.
[Abstract] [Full Text] [PDF]


Home page
JGPHome page
T. Vaithianathan, A. Bukiya, J. Liu, P. Liu, M. Asuncion-Chin, Z. Fan, and A. Dopico
Direct Regulation of BK Channels by Phosphatidylinositol 4,5-Bisphosphate as a Novel Signaling Pathway
J. Gen. Physiol., July 1, 2008; 132(1): 13 - 28.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics